US Stock MarketDetailed Quotes

CADL Candel Therapeutics

Watchlist
  • 5.680
  • +0.370+6.97%
Close Aug 23 16:00 ET
  • 5.680
  • 0.0000.00%
Post 20:01 ET
182.24MMarket Cap-3341P/E (TTM)

Candel Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0.00%125K
0.00%31K
0.00%31K
Operating revenue
--0
--0
--0
--0
--0
--0
--0
0.00%125K
0.00%31K
0.00%31K
Cost of revenue
Gross profit
Operating expense
-10.41%8.57M
-17.87%7.9M
10.32%38.39M
28.08%10.35M
-0.71%8.85M
8.91%9.57M
6.70%9.62M
40.46%34.8M
6.06%8.08M
12.40%8.91M
Selling and administrative expenses
-1.45%3.59M
-8.74%3.8M
-1.24%13.89M
-3.16%3.06M
-14.71%3.02M
-3.11%3.65M
15.67%4.16M
31.73%14.06M
-19.33%3.16M
26.51%3.54M
-General and administrative expense
-1.45%3.59M
-8.74%3.8M
-1.24%13.89M
-3.16%3.06M
-14.71%3.02M
-3.11%3.65M
15.67%4.16M
31.73%14.06M
-19.33%3.16M
26.51%3.54M
Research and development costs
-16.09%4.98M
-25.00%4.1M
17.89%24.51M
45.98%7.26M
8.72%5.85M
18.16%5.93M
0.96%5.47M
36.95%20.79M
29.01%4.97M
2.11%5.38M
Other operating expenses
----
----
----
----
---12K
---12K
---12K
95.54%-48K
----
----
Operating profit
10.41%-8.57M
17.87%-7.9M
-10.72%-38.39M
-28.57%-10.35M
0.36%-8.85M
-9.30%-9.57M
-7.07%-9.62M
-40.67%-34.67M
-6.09%-8.05M
-12.45%-8.88M
Net non-operating interest income expense
-71.20%-327K
-419.61%-326K
-4.90%-514K
-214.16%-258K
5.11%-167K
47.67%-191K
158.29%102K
-824.53%-490K
2,154.55%226K
-1,157.14%-176K
Non-operating interest income
-47.02%240K
-54.99%320K
70.85%2.08M
-48.38%415K
46.36%502K
547.14%453K
--711K
--1.22M
--804K
--343K
Non-operating interest expense
-11.96%567K
6.08%646K
51.93%2.6M
16.44%673K
28.90%669K
48.05%644K
--609K
--1.71M
--578K
--519K
Other net income (expense)
-9,363.19%-13.34M
-99.03%7K
-94.10%966K
-117.60%-483K
57.45%581K
-97.10%144K
-91.26%724K
243.33%16.37M
-70.17%2.74M
104.47%369K
Gain on sale of security
-9,363.19%-13.34M
-99.03%7K
-94.10%966K
-117.60%-483K
57.45%581K
-97.10%144K
-91.26%724K
243.33%16.37M
-70.17%2.74M
104.47%369K
Income before tax
-131.30%-22.24M
6.53%-8.22M
-101.87%-37.94M
-118.28%-11.1M
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.8M
47.97%-18.79M
-418.48%-5.08M
46.24%-8.69M
Income tax
Net income
-131.30%-22.24M
6.53%-8.22M
-101.87%-37.94M
-118.28%-11.1M
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.8M
47.97%-18.79M
-418.48%-5.08M
46.24%-8.69M
Net income continuous Operations
-131.30%-22.24M
6.53%-8.22M
-101.87%-37.94M
-118.28%-11.1M
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.8M
47.97%-18.79M
-418.48%-5.08M
46.24%-8.69M
Minority interest income
Net income attributable to the parent company
-131.30%-22.24M
6.53%-8.22M
-101.87%-37.94M
-118.28%-11.1M
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.8M
47.97%-18.79M
-418.48%-5.08M
46.24%-8.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-131.30%-22.24M
6.53%-8.22M
-101.87%-37.94M
-118.28%-11.1M
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.8M
47.97%-18.79M
-418.48%-5.08M
46.24%-8.69M
Basic earnings per share
-124.24%-0.74
6.67%-0.28
-101.54%-1.31
-111.11%-0.38
3.33%-0.29
-135.71%-0.33
-900.00%-0.3
65.97%-0.65
-423.57%-0.18
56.52%-0.3
Diluted earnings per share
-124.24%-0.74
6.67%-0.28
-101.54%-1.31
-111.11%-0.38
3.33%-0.29
-135.71%-0.33
-900.00%-0.3
65.97%-0.65
-423.57%-0.18
56.52%-0.3
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 00000000.00%125K0.00%31K0.00%31K
Operating revenue --0--0--0--0--0--0--00.00%125K0.00%31K0.00%31K
Cost of revenue
Gross profit
Operating expense -10.41%8.57M-17.87%7.9M10.32%38.39M28.08%10.35M-0.71%8.85M8.91%9.57M6.70%9.62M40.46%34.8M6.06%8.08M12.40%8.91M
Selling and administrative expenses -1.45%3.59M-8.74%3.8M-1.24%13.89M-3.16%3.06M-14.71%3.02M-3.11%3.65M15.67%4.16M31.73%14.06M-19.33%3.16M26.51%3.54M
-General and administrative expense -1.45%3.59M-8.74%3.8M-1.24%13.89M-3.16%3.06M-14.71%3.02M-3.11%3.65M15.67%4.16M31.73%14.06M-19.33%3.16M26.51%3.54M
Research and development costs -16.09%4.98M-25.00%4.1M17.89%24.51M45.98%7.26M8.72%5.85M18.16%5.93M0.96%5.47M36.95%20.79M29.01%4.97M2.11%5.38M
Other operating expenses -------------------12K---12K---12K95.54%-48K--------
Operating profit 10.41%-8.57M17.87%-7.9M-10.72%-38.39M-28.57%-10.35M0.36%-8.85M-9.30%-9.57M-7.07%-9.62M-40.67%-34.67M-6.09%-8.05M-12.45%-8.88M
Net non-operating interest income expense -71.20%-327K-419.61%-326K-4.90%-514K-214.16%-258K5.11%-167K47.67%-191K158.29%102K-824.53%-490K2,154.55%226K-1,157.14%-176K
Non-operating interest income -47.02%240K-54.99%320K70.85%2.08M-48.38%415K46.36%502K547.14%453K--711K--1.22M--804K--343K
Non-operating interest expense -11.96%567K6.08%646K51.93%2.6M16.44%673K28.90%669K48.05%644K--609K--1.71M--578K--519K
Other net income (expense) -9,363.19%-13.34M-99.03%7K-94.10%966K-117.60%-483K57.45%581K-97.10%144K-91.26%724K243.33%16.37M-70.17%2.74M104.47%369K
Gain on sale of security -9,363.19%-13.34M-99.03%7K-94.10%966K-117.60%-483K57.45%581K-97.10%144K-91.26%724K243.33%16.37M-70.17%2.74M104.47%369K
Income before tax -131.30%-22.24M6.53%-8.22M-101.87%-37.94M-118.28%-11.1M2.91%-8.44M-131.72%-9.61M-906.29%-8.8M47.97%-18.79M-418.48%-5.08M46.24%-8.69M
Income tax
Net income -131.30%-22.24M6.53%-8.22M-101.87%-37.94M-118.28%-11.1M2.91%-8.44M-131.72%-9.61M-906.29%-8.8M47.97%-18.79M-418.48%-5.08M46.24%-8.69M
Net income continuous Operations -131.30%-22.24M6.53%-8.22M-101.87%-37.94M-118.28%-11.1M2.91%-8.44M-131.72%-9.61M-906.29%-8.8M47.97%-18.79M-418.48%-5.08M46.24%-8.69M
Minority interest income
Net income attributable to the parent company -131.30%-22.24M6.53%-8.22M-101.87%-37.94M-118.28%-11.1M2.91%-8.44M-131.72%-9.61M-906.29%-8.8M47.97%-18.79M-418.48%-5.08M46.24%-8.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -131.30%-22.24M6.53%-8.22M-101.87%-37.94M-118.28%-11.1M2.91%-8.44M-131.72%-9.61M-906.29%-8.8M47.97%-18.79M-418.48%-5.08M46.24%-8.69M
Basic earnings per share -124.24%-0.746.67%-0.28-101.54%-1.31-111.11%-0.383.33%-0.29-135.71%-0.33-900.00%-0.365.97%-0.65-423.57%-0.1856.52%-0.3
Diluted earnings per share -124.24%-0.746.67%-0.28-101.54%-1.31-111.11%-0.383.33%-0.29-135.71%-0.33-900.00%-0.365.97%-0.65-423.57%-0.1856.52%-0.3
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg